Biofil Chemicals

{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.98",
    "chg": 0.34,
    "chgp": "1.04%",
    "dir": 1,
    "prev_price": "32.64",
    "mcapval": "53.67 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE829A01014",
    "curr_date": "Aug 12, 03:20 PM",
    "curr_time": "15:39 PM",
    "last_traded_at": "Aug 12, 03:20 PM IST",
    "bse_nse_vol": "3.42 k",
    "exc_status": "Active",
    "traded_date": "Aug 12, 2026",
    "traded_date_str": "2026 08 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-upgraded-to-sell-on-technical-improvements-4149528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_mojoScore_4149528.png",
        "date": "2026-08-12 08:28:08",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental challenges. This nuanced change reflects a mildly improved technical outlook amid ongoing financial underperformance and valuation considerations within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-4134670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_mojoScore_4134670.png",
        "date": "2026-08-04 10:11:02",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4114955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiofilChemicals_mojoScore_4114955.png",
        "date": "2026-07-22 10:11:29",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4096177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiofilChemicals_mojoScore_4096177.png",
        "date": "2026-07-10 10:11:09",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4076757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_mojoScore_4076757.png",
        "date": "2026-06-29 10:11:09",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4058701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_mojoScore_4058701.png",
        "date": "2026-06-17 10:11:42",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Biofil Chemicals Gains 1.17%: Technical and Valuation Shifts Drive Weekly Movement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-gains-117-technical-and-valuation-shifts-drive-weekly-movement-4052941",
        "imagepath": "",
        "date": "2026-06-14 11:01:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Q4 FY26 results reveal exceptional income masking operational weakness</p>\n                    <p><strong>1 June:</strong> MarketsMOJO upgrades rating to Sell on improved technicals and valuation</p>\n                    <p><strong>5 June:</strong> Stock rallies 3.11% on strong volume, closing at Rs.35.52</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.35.11</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.35.52</div><div class=\"stat-change positive\">+1.17%</div></di..."
      },
      {
        "title": "Are Biofil Chemicals & Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-biofil-chemicals-pharmaceuticals-ltd-latest-results-good-or-bad-4028070",
        "imagepath": "",
        "date": "2026-06-01 19:26:31",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported net sales of ₹7.57 crores, reflecting a significant quarter-on-quarter growth of 780.23% from the previous quarter's ₹0.86 crores. However, this surge is contrasted by a year-on-year decline of 9.34%, indicating ongoing demand challenges despite the apparent recovery.\n\nNet profit for the quarter stood at ₹0.21 crores, which is a 162.50% increase compared to the previous quarter, and a 5.00% increase year-on-year. While this uptick in profit may seem positive, it is essential to note that the overall operational performance remains inconsistent. The operating margin decreased to 5.68% from 11.63% in the prior quarter, suggesting rising input costs or unfavorable product mix despite higher sales.\n\nThe volatility in revenue is a critical concern, with sales flu..."
      },
      {
        "title": "Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness",
        "link": "https://www.marketsmojo.com/news/result-analysis/biofil-chemicals-q4-fy26-exceptional-income-masks-operational-weakness-4026683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_quaterlyResult_4026683.png",
        "date": "2026-06-01 10:51:39",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹57.00 crores, reported net profit of ₹0.21 crores in Q4 FY26 (Mar'26), marking a modest 5.00% increase year-on-year but a substantial 162.50% surge quarter-on-quarter. However, this apparent profitability improvement conceals deeper operational challenges, as the company's core business performance remains under significant pressure with volatile revenue patterns and contracting margins."
      }
    ],
    "total": 192,
    "sid": "386748",
    "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended 30th September 2019 pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Biofil Chemicals & Pharmaceuticals Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Extracts of Financial Results for Quarter and half year ended 30th September, 2019 published in News Paper i.e. Free press Mumbai & Indore (in English) and Choutha Sansar (in Hindi) on 16th November, 2019.'.",
      "source": "NSE",
      "caption": "Biofil Chemicals & Pharmaceuticals Limited - Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI(Listing Obligation and Disclosure Requirement) Regulations 2015, Please find enclosed public notice which was published on in Free Press, Indore and The Free Press Journal, Mumbai (in English) and Choutha Sansar, Indore (in hindi) for the upcoming Board Meeting scheduled on 14th November 2019.",
      "source": "NSE",
      "caption": "Biofil Chemicals & Pharmaceuticals Limited - Updates",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements

2026-08-12 08:28:08

Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental challenges. This nuanced change reflects a mildly improved technical outlook amid ongoing financial underperformance and valuation considerations within the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell

2026-08-04 10:11:02

Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-07-22 10:11:29

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-07-10 10:11:09

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-06-29 10:11:09

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-06-17 10:11:42

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Biofil Chemicals Gains 1.17%: Technical and Valuation Shifts Drive Weekly Movement

2026-06-14 11:01:34

Key Events This Week

1 June: Q4 FY26 results reveal exceptional income masking operational weakness

1 June: MarketsMOJO upgrades rating to Sell on improved technicals and valuation

5 June: Stock rallies 3.11% on strong volume, closing at Rs.35.52

Week Open

Rs.35.11

Week Close

Rs.35.52

+1.17%

Read full news article

Are Biofil Chemicals & Pharmaceuticals Ltd latest results good or bad?

2026-06-01 19:26:31

Biofil Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported net sales of ₹7.57 crores, reflecting a significant quarter-on-quarter growth of 780.23% from the previous quarter's ₹0.86 crores. However, this surge is contrasted by a year-on-year decline of 9.34%, indicating ongoing demand challenges despite the apparent recovery. Net profit for the quarter stood at ₹0.21 crores, which is a 162.50% increase compared to the previous quarter, and a 5.00% increase year-on-year. While this uptick in profit may seem positive, it is essential to note that the overall operational performance remains inconsistent. The operating margin decreased to 5.68% from 11.63% in the prior quarter, suggesting rising input costs or unfavorable product mix despite higher sales. The volatility in revenue is a critical concern, with sales flu...

Read full news article

Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness

2026-06-01 10:51:39

Biofil Chemicals & Pharmaceuticals Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹57.00 crores, reported net profit of ₹0.21 crores in Q4 FY26 (Mar'26), marking a modest 5.00% increase year-on-year but a substantial 162.50% surge quarter-on-quarter. However, this apparent profitability improvement conceals deeper operational challenges, as the company's core business performance remains under significant pressure with volatile revenue patterns and contracting margins.

Read full news article

View All News